Bridge to Life, a US-based company supplying organ preservation solutions and perfusion technologies, has completed a US$110m Series C and debt financing. The equity financing was led by new investor US-based Soleus Capital, along with Paris- and US-based…
US: Bridge to Life completes US$110m Series C and debt financing to fuel the company’s VitaSmart launch
…
…






